As an aside, at the recent Atomo Diagnostics AGM, Atomo was asked how they were preparing to support the release of FebriDX into the US market.
While they noted that the approval was certainly a big deal, they did not see the demand to be there in the short term - but rather the medium to long term. They added that any substantial increase in demand would take a significant amount of time, but then - once established - would result in steady partnerships for 5 to 10 years.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
-0.002(6.90%) |
Mkt cap ! $20.21M | |||
| Open | High | Low | Value | Volume |
| 2.8¢ | 2.8¢ | 2.7¢ | $37.38K | 1.357M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 337500 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.7¢ | 942945 | 1 |
View Market Depth
| Last trade - 15.55pm 23/06/2025 (20 minute delay) ? |
| LDX (ASX) Chart |